IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#4777
Positioning
Market Dominance
Manufacturing
Pharmaceutical Products
$3M
James Foster
Virax Cayman is a holding company incorporated as an exempted company under the laws of the Cayman Islands. As a holding company with no material operations of our own, Virax Cayman conducts our operations through its operating subsidiaries in Singapore, Hong Kong, China and British Virgin Islands and has been operating since 2013. Our principal executive office is located at 30 Broadwick Street London, W1F 8LX, United Kingdom. Our telephone number is +44 020 7788 7414. Our registered office in the Cayman Islands is located at the office of Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands. Our agent for service of process in the United States is Cogency Global Inc., located at 122 East 42nd Street, 18th Floor, New York, NY.
Headcount
5
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$VRAX Virax Biolabs Group Ltd | 25 | 18 | 22 | 3 | - | - | -426.1% | -377.6% | - | - | - | -100.0% | 0.0% | 6.0x | $3M | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
Virax Biolabs Group Ltd (VRAX) receives a "Avoid" rating with a composite score of 24.8/100. It ranks #4777 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
James Foster
Chief Executive Officer
Labor Force
5
18
28
30
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for VRAX
HQ Base
Pending Verification
Lagging peers — losers tend to keep underperforming
Expensive relative to fundamentals — limited margin of safety
Weak fundamentals — higher risk of value trap
High volatility — wider range of outcomes increases timing risk
Aggressive spending — empire-building risk, dilutive growth
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for VRAX.
View All RatingsInsufficient data for Financial Analysis
ROE proxy -426.1% (sector -2.5%)
GM N/A vs sector 43%, OM N/A vs sector 1%
Capital turnover N/A
Rev growth -100%, 4yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our quantitative model flags Virax Biolabs Group Ltd with an Avoid rating, assigning a composite score of 24.8/100 and 1 out of 5 stars. Ranked #4777 of 7,333 stocks, VRAX falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
Virax Biolabs Group Ltd registers a weak quality score of just 18/100, indicating significant profitability challenges. The company reports a return on equity of -426.1% (sector avg: -2.5%). Low quality scores are often associated with businesses in turnaround mode, early-stage growth, or structurally challenged industries.
VRAX registers a value score of just 22/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include a P/B ratio of 0.27x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
Virax Biolabs Group Ltd's investment score of 28/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -100.0% vs. a sector average of 5.9% and a return on assets of -377.6% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
Virax Biolabs Group Ltd is experiencing notably weak momentum with a score of just 3/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at -100.0% year-over-year, while a beta of 1.17 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
VRAX's stability score of 30/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of 1.17 and a debt-to-equity ratio of 6.00x (sector avg: 0.2x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
The short interest score of 59/100 for VRAX suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 6.00x), micro-cap liquidity risk. With a $3M market cap (micro-cap), Virax Biolabs Group Ltd may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
Virax Biolabs Group Ltd is a micro-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #4777 of 7,333 overall (35th percentile). Key comparisons include ROE of -426.1% trailing the -2.5% sector median. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While VRAX currently exhibits a AVOID profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Momentum (3) would have the largest impact on the composite score.
ROE 17080% ABOVE SECTOR MEDIAN (FAVORABLE)
Debt/Equity 2900% ABOVE SECTOR MEDIAN
Div. Yield NaN% BELOW SECTOR MEDIAN
AUDIT DATA AS OF MAR 31, 2025 (Q4 FY2024)
We rate Virax Biolabs Group Ltd (VRAX) as Avoid with a composite score of 24.8/100 at a current price of $0.23. The stock falls in the bottom quintile of our universe across key quantitative factors, and the multi-factor weakness suggests a high probability of continued underperformance.
The rating is primarily driven by strength in stability (30th percentile) and investment (28th percentile), which together account for the majority of the composite score. Offsetting weakness in momentum (3th percentile) and quality (18th percentile) tempers our overall conviction. We assign a No Moat rating (20/100), Medium uncertainty, and Poor capital allocation.
Key items to watch: momentum to confirm whether the current price trend has legs; valuation compression risk if growth disappoints. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
Virax Biolabs Group Ltd holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 24.8/100 places it at rank #4777 in our full 7,333-stock universe. At $3M in market capitalization, Virax Biolabs Group Ltd is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue contraction of -100% combined with momentum at the 3th percentile paints a cautious picture of the near-term business outlook. The market appears to be pricing in continued challenges, and a catalyst for reversal is not clearly visible from current data.
Margin data is not available for Virax Biolabs Group Ltd, which limits our assessment of the company's cost structure and operating efficiency. We rely on factor-based signals to infer business quality in the absence of detailed margin data.
At a current price of $0.23, Virax Biolabs Group Ltd is trading at a premium to fundamental value. Our value factor score of 22/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The premium valuation implies the market is pricing in significant future growth or quality improvements that are not yet fully reflected in current fundamentals.
The stock currently trades at P/B of 0.3x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
A conservative balance sheet (6% D/E) provides financial flexibility for acquisitions, buybacks, or weathering economic downturns without dilution.
The Avoid rating (composite 24.8/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Revenue decline of -100% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
Weak momentum (3th percentile) suggests institutional selling pressure and unfavorable technical dynamics that may persist.
Below-average quality (18th percentile) raises durability concerns about the fundamental profile and increases the risk of negative earnings surprises.
We assign a Medium uncertainty rating to Virax Biolabs Group Ltd. The stock presents a balanced risk profile: below-average price stability (30th percentile) and weak quality scores (18th percentile). While not risk-free, the core business fundamentals are adequate to withstand moderate economic stress, and the range of potential outcomes around our fair value estimate is manageable.
Specific risk factors that inform our assessment include: below-average price stability (30th percentile); weak quality scores (18th percentile). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 30th percentile and quality factor at the 18th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: conservative leverage (6% D/E) limits balance sheet risk. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate Virax Biolabs Group Ltd's capital allocation as Poor. Key concerns include low returns on equity (-426.1%), weak asset returns (ROA -377.6%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — Virax Biolabs Group Ltd significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, Virax Biolabs Group Ltd receives a Avoid rating with a composite score of 24.8/100 (rank #4777 of 7,333). Our quantitative framework assigns a No Moat (20/100, trend: stable), Medium uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 20/100.
Our analysis does not support a constructive view on Virax Biolabs Group Ltd at this time. The combination of limited competitive advantages, medium uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign Virax Biolabs Group Ltd a meaningful economic moat, scoring 20/100 on our composite assessment. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 7.5/20.
The strongest moat sources are margin superiority (7.5/20) and financial resilience (6.8/20). GM N/A vs sector 43%, OM N/A vs sector 1%. Interest coverage N/A. These pillars form the core of Virax Biolabs Group Ltd's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (0/20) and economic value creation (2.5/20). Capital turnover N/A. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect Virax Biolabs Group Ltd's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include declining revenues (-100%) that pressure the earnings outlook. Our analysis indicates that profit quality raises some durability concerns, with the quality factor at the 18th percentile.
Return metrics include ROE of -426.1% and ROA of -377.6%. Relative to the Manufacturing sector, sector comparison data is limited, and ROE of -426.1% compares to a sector median of -2.5%.
The balance sheet reflects a conservatively managed balance sheet with D/E of 6%, revenue growth of -100%. The sector median D/E is 0%, putting Virax Biolabs Group Ltd at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Above 50MA
37.18%
Net New Highs
+51081
Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company dedicated to the advancement of immunology research and diagnostics, announced today the closing of its previously announced private placement of its securities for total gross proceeds of $5 million, before deducting placement agent fees and other offering expenses.
Shares of LQR House Inc. (NASDAQ: LQR) rose sharply in pre-market trading. Borg's investor group has acquired a 20% stake in LQR House. LQR House shares jumped 16.1% to $4.25 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares rose 64% to $2.28 in pre-market trading after gaining over 13% on Friday. Phunware, Inc. (NASDAQ: PHUN) shares jumped 34.5% to $0.1021 in pre-market trading. MorphoSys AG (NASDAQ: MOR) gained 18.8% to $10.21 in pre-market trading. Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 13.6% to $1.17 in pre-market trading after falling more than 6% on Friday. U Power Limited (NASDAQ: UCAR) shares gained 12.7% to $0.1459 in pre-market trading. WISeKey International Holding AG (NASDAQ: WKEY) gained 11.8% to $2.87 in pre-market trading. SEALSQ launched SEALCOIN.AI in partnership with Google Cloud. Agenus Inc. (NASDAQ: ...
Shares of Trinity Place Holdings Inc. (NYSE: TPHS) rose sharply in pre-market trading. The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan. 31, 2024. Trinity Place shares jumped 80.1% to $0.2056 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Sigma Additive Solutions, Inc.(NASDAQ: SASI) gained 68.6% to $4.89 in pre-market trading. Sigma Additive Solutions was recently granted U.S. patent #11858207: Defect detection for additive manufacturing systems. Carbon Revolution Public Limited Company (NASDAQ: CREV) rose 36.8% to $31.88 in pre-market trading. Rail Vision Ltd. (NASDAQ: RVSN) shares rose 29.5% to $1.62 in pre-market trading after dipping over 15% on Tuesday. First Wave BioPharma, Inc. (NASDAQ: FWBI) shares gained 25.9% to $4.81 in pre-market trading. Roth MKM raised price target on the stock to $40. China Liberal Education Holdings ...
Shares of Bridgeline Digital, Inc. (NASDAQ: BLIN) fell sharply in pre-market following the release of fourth-quarter results. Bridgeline Digital posted a narrower-than-expected loss for its fourth quarter, while sales missed estimates. Bridgeline Digital shares dipped 13.1% to $0.7805 in pre-market. Here are some other stocks moving in pre-market trading. Gainers Cingulate Inc. (NASDAQ: CING) shares gained 233.3% to $13.30 in pre-market trading after surging more than 90% on Wednesday. SenesTech, Inc.(NASDAQ: SNES) gained 91.3% to $1.65 in pre-market trading after gaining around 8% on Wednesday. SenesTech recently announced entry into a Distribution Agreement with Fruit Tree Limited and an initial order for Evolve Soft Bait in Hong Kong and Macau. Nxu, Inc. (NASDAQ: NXU) rose 44.8% to $3.85 in pre-market trading after falling around 15% on Wednesday. Nxu executed definitive documents to finalize its strategic investment in Lynx Motors. noco-noco Inc. (NASDAQ: NCNC) shares rose 29.3% to $0.2550 in pre-market trading. Noco-Noco recently filed prospectus relates to offer and resale from time to time by selling stockholders of up to 100.3 ...
On Thursday, 498 companies reached new 52-week lows. Things to Consider About Today's 52-Week Lows: Pfizer (NYSE:PFE) was the biggest company in terms of market cap to set a new 52-week low. The smallest company by market cap to set a new 52-week low was NovaBay Pharmaceuticals (AMEX:NBY). Mullen Automotive (NASDAQ:MULN)'s stock traded down the lowest, falling 2028.33% to reach a new 52-week low. Innoviz Technologies (NASDAQ:INVZ) shares were the most resilient, as shares rose 0.0%, rebounding from its new 52-week low. The following stocks created new 52-week lows on Thursday: Pfizer (NYSE:PFE) stock drifted down 0.18% on Thursday morning to hit a new 52-week low of $38.02. CVS Health (NYSE:CVS) stock hit a new 52-week low of $68.10. The stock was down 1.79% on the session. General Dynamics (NYSE:GD) stock set a new 52-week low of $205.44 on Thursday, moving down 1.55%. PNC Finl Servs Gr (NYSE:PNC) shares set a new 52-week low of $111.86. The stock traded down 1.18%. U.S. Bancorp (NYSE:USB) stock hit a yearly low of $27.27. The stock was down 3.05% for the day. Truist Finl (NYSE:TFC) stock hit a new 52-week low of $25.56. The stock was down 5.28% on the session. L3Harris Technologies (NYSE:LHX) stock set a new 52-week low of $183.42 on Thursday, moving down 0.85%. Nutrien (NYSE:NTR) stock drifted down 3.56% on Thursday morning to hit a new 52-week low of $64.28. Nokia (NYSE:NOK) shares hit a yearly low of $4.01. The stock was down 0.62% on the session. M&T Bank (NYSE:MTB) shares reached a new 52-week low of $109.40 on Thursday morning, moving down 1.95%. Ecopetrol (NYSE:EC) shares set a new 52-week low of $8.59. The stock traded down 1.32%. Northern Trust (NASDAQ:NTRS) stock dropped to a yearly low on Thursday of $70.68. Shares traded down 2.18%. Huntington Bancshares (NASDAQ:HBAN) shares hit a yearly low of $9.21. The stock was down 4.32% on the session. Mosaic (NYSE:MOS) stock hit a new 52-week low of $38.42. The stock was down 8.2% on the session. Citizens Financial Group (NYSE:CFG) shares made a new 52-week low of $23.38 on Thursday. The stock was down 5.34% for the day. Icahn Enterprises (NASDAQ:IEP) stock drifted down 4.05% on Thursday morning to hit a new 52-week low of $28.30. KeyCorp (NYSE:KEY) stock hit a yearly low of $8.54. The stock was down 4.35% for the day. Equitable Hldgs (NYSE:EQH) shares set a new 52-week low of $22.05. The stock traded down 7.78%. ICL Group (NYSE:ICL) stock achieved a new 52-week low on Thursday morning, hitting $5.91 and moving down 2.76%. Huntington Ingalls Indus (NYSE:HII) stock hit $188.51 on Thursday morning, setting a new 52-week low for a change of down 2.86%. HF Sinclair (NYSE:DINO) stock broke to a new 52-week low of $38.39 on Thursday. Shares of the company traded down 7.23%. Commerce Bancshares (NASDAQ:CBSH) shares made a new 52-week low of $50.37 on Thursday. The stock was down 2.61% for the day. UGI (NYSE:UGI) stock dropped to a yearly low on Thursday of $29.67. Shares traded down 6.17%. Jones Lang LaSalle (NYSE:JLL) stock drifted down 2.27% on Thursday morning to hit a new 52-week low of $123.41. Cullen/Frost Bankers (NYSE:CFR) stock dropped to a yearly low on Thursday of $92.55. Shares traded down 2.95%. Antero Resources (NYSE:AR) shares were down 0.17% for the day, having made a 52-week low of $20.27. Sealed Air (NYSE:SEE) shares moved down 1.26% on Thursday to hit a new 52-week low of $41.15, drifting down 1.26%. Webster Finl (NYSE:WBS) shares fell to $31.03 on Thursday, setting a new 52-week low with a shift of down 2.1%. Prosperity Bancshares (NYSE:PB) stock drifted down 0.75% on Thursday morning to hit a new 52-week low of $56.72. Wolfspeed (NYSE:WOLF) shares were down 4.02% for the day, having made a 52-week low of $40.52. First Horizon (NYSE:FHN) shares hit a yearly low of $8.99. The stock was down 36.18% on the session. Clarivate (NYSE:CLVT) stock dropped to a yearly low on Thursday of $7.56. Shares traded down 3.3%. Southwestern Energy (NYSE:SWN) shares moved down 0.54% on Thursday to hit a new 52-week low of $4.57, drifting down 0.54%. Ashland (NYSE:ASH) shares made a new 52-week low of $88.60 on Thursday. The stock was down 1.54% for the day. NextEra Energy Partners (NYSE:NEP) stock hit a new 52-week low of $52.39. The stock was down 1.97% on the session. ADT (NYSE:ADT) shares reached a new 52-week low of $4.96 on Thursday morning, moving down 4.07%. Concentrix (NASDAQ:CNXC) shares fell to $88.45 on Thursday, setting a new 52-week low with a shift of down 2.73%. Option Care Health (NASDAQ:OPCH) stock drifted down 24.35% on Thursday morning to hit a new 52-week low of $24.23. DT Midstream (NYSE:DTM) shares set a new 52-week low of $45.10. The stock traded up 0.24%. Dun & Bradstreet Hldgs (NYSE:DNB) shares set a new 52-week low of $9.91. The stock traded down 0.64%. Rayonier (NYSE:RYN) shares were down 4.91% for the day, having made a 52-week low of $27.81. Comerica (NYSE:CMA) shares set a new 52-week low of $28.42. The stock traded down 8.92%. Halozyme Therapeutics (NASDAQ:HALO) shares moved down 3.36% on Thursday to hit a new 52-week low of $30.95, drifting down 3.36%. HealthEquity (NASDAQ:HQY) shares hit a yearly low of $48.86. The stock was down 2.64% on the session. GitLab (NASDAQ:GTLB) stock broke to a new 52-week low of $26.73 on Thursday. Shares of the company traded down 3.76%. Informatica (NYSE:INFA) stock hit a new 52-week low of $13.30. The stock was down 3.85% on the session. United Bankshares (NASDAQ:UBSI) stock set a new 52-week low of $28.29 on Thursday, moving down 0.96%. Macy's (NYSE:M) shares made a new 52-week low of $14.64 on Thursday. The stock was down 3.7% for the day. First Finl Bankshares (NASDAQ:FFIN) stock achieved a new 52-week low on Thursday morning, hitting $26.75 and moving down 1.9%. Synovus Finl (NYSE:SNV) shares fell to $25.33 on Thursday, setting a new 52-week low with a shift of down 4.0%. Southwest Gas Hldgs (NYSE:SWX) stock dropped to a yearly low on Thursday of $53.85. Shares traded down 1.87%. F N B (NYSE:FNB) shares hit a yearly low of $10.09. The stock was down 1.82% on the session. Bank OZK (NASDAQ:OZK) shares moved down 3.18% on Thursday to hit a new 52-week low of $31.00, drifting down 3.18%. Valley Ntl (NASDAQ:VLY) shares set a new yearly low of $6.64 this morning. The stock was down 0.68% on the session. MP Materials (NYSE:MP) shares hit a yearly low of $20.22. The stock was down 0.34% on the session. Old National (NASDAQ:ONB) stock set a new 52-week low of $11.66 on Thursday, moving down 1.59%. DISH Network (NASDAQ:DISH) shares hit a yearly low of $6.59. The stock was down 3.86% on the session. Pinnacle Finl Partners (NASDAQ:PNFP) shares reached a new 52-week low of $43.31 on Thursday morning, moving down 2.94%. Clearway Energy (NYSE:CWEN) shares set a new 52-week low of $28.77. The stock traded down 1.27%. Cadence Bank (NYSE:CADE) shares moved down 1.0% on Thursday to hit a new 52-week low of $16.95, drifting down 1.0%. Kilroy Realty (NYSE:KRC) shares reached a new 52-week low of $26.71 on Thursday morning, moving up 0.66%. ASGN (NYSE:ASGN) shares moved down 4.4% on Thursday to hit a new 52-week low of $64.61, drifting down 4.4%. Helmerich & Payne (NYSE:HP) shares reached a new 52-week low of $30.46 on Thursday morning, moving down 0.37%. TFS Financial (NASDAQ:TFSL) shares were down 0.4% for the day, having made a 52-week low of $11.05. Glacier Bancorp (NYSE:GBCI) stock hit $26.79 on Thursday morning, setting a new 52-week low for a change of down 3.63%. Ziff Davis (NASDAQ:ZD) shares fell to $65.86 on Thursday, setting a new 52-week low with a shift of down 2.1%. Zions Bancorp (NASDAQ:ZION) shares set a new 52-week low of $18.26. The stock traded down 7.61%. Armstrong World Indus (NYSE:AWI) shares made a new 52-week low of $65.73 on Thursday. The stock was down 0.67% for the day. Synaptics (NASDAQ:SYNA) shares reached a new 52-week low of $67.73 on Thursday morning, moving down 18.16%. Hancock Whitney (NASDAQ:HWC) shares were down 3.71% for the day, having made a 52-week low of $31.09. Comstock Resources (NYSE:CRK) shares set a new 52-week low of $9.44. The stock traded down 2.66%. UMB Financial (NASDAQ:UMBF) shares set a new yearly low of $50.68 this morning. The stock was down 3.89% on the session. Lazard (NYSE:LAZ) stock drifted down 2.15% on Thursday morning to hit a new 52-week low of $28.50. RingCentral (NYSE:RNG) stock hit a new 52-week low of $25.60. The stock was up 0.58% on the session. United Community Banks (NASDAQ:UCBI) stock hit a yearly low of $20.37. The stock was down 2.73% for the day. First Interstate BancSys (NASDAQ:FIBK) shares made a new 52-week low of $21.94 on Thursday. The stock was down 2.75% for the day. Servisfirst Bancshares (NYSE:SFBS) shares fell to $42.71 on Thursday, setting a new 52-week low with a shift of down 2.44%. Outfront Media (NYSE:OUT) stock set a new 52-week low of $14.51 on Thursday, moving down 8.91%. CVR Energy (NYSE:CVI) shares reached a new 52-week low of $23.61 on Thursday morning, moving down 3.54%. BancFirst (NASDAQ:BANF) shares moved down 2.72% on Thursday to hit a new 52-week low of $68.44, drifting down 2.72%. Associated Banc (NYSE:ASB) stock broke to a new 52-week low of $14.66 on Thursday. Shares of the company traded down 3.35%. Nordstrom (NYSE:JWN) shares hit a yearly low of $14.09. The stock was down 3.29% on the session. Alarm.com Holdings (NASDAQ:ALRM) shares hit a yearly low of $45.09. The stock was down 0.22% on the session. TripAdvisor (NASDAQ:TRIP) stock dropped to a yearly low on Thursday of $14.38. Shares traded down 7.51%. Texas Capital Bancshares (NASDAQ:TCBI) shares set a new yearly low of $43.37 this morning. The stock was down 3.29% on the session. Kohl's (NYSE:KSS) shares moved down 3.17% on Thursday to hit a new 52-week low of $19.41, drifting down 3.17%. Patterson-UTI Energy (NASDAQ:PTEN) stock dropped to a yearly low on Thursday of $10.19. Shares traded up 0.73%. First Hawaiian (NASDAQ:FHB) shares moved down 1.23% on Thursday to hit a new 52-week low of $16.28, drifting down 1.23%. National Health Investors (NYSE:NHI) stock set a new 52-week low of $47.66 on Thursday, moving down 0.78%. Ameris (NASDAQ:ABCB) stock hit a yearly low of $28.33. The stock was down 2.28% for the day. Cathay General (NASDAQ:CATY) shares reached a new 52-week low of $27.25 on Thursday morning, moving down 2.3%. Kennedy-Wilson Holdings (NYSE:KW) stock dropped to a yearly low on Thursday of $14.01. Shares traded down 10.58%. Cushman & Wakefield (NYSE:CWK) shares fell to $8.71 on Thursday, setting a new 52-week low with a shift of down 3.67%. Simmons First Ntl (NASDAQ:SFNC) stock achieved a new 52-week low on Thursday morning, hitting $14.99 and moving down 0.76%. SunPower (NASDAQ:SPWR) stock achieved a new 52-week low on Thursday morning, hitting $11.13 and moving down 6.0%. ZIM Integrated Shipping (NYSE:ZIM) stock hit a yearly low of $16.20. The stock was down 2.16% for the day. First BanCorp (NYSE:FBP) stock hit a yearly low of $10.18. The stock was up 0.37% for the day. WSFS Financial (NASDAQ:WSFS) stock hit a new 52-week low of $29.86. The stock was down 4.61% on the session. F&G Annuities & Life (NYSE:FG) shares hit a yearly low of $14.81. The stock was down 16.81% on the session. MaxLinear (NASDAQ:MXL) shares set a new 52-week low of $23.05. The stock traded down 3.07%. Eastern Bankshares (NASDAQ:EBC) shares hit a yearly low of $9.93. The stock was down 0.57% on the session. First Financial Bancor (NASDAQ:FFBC) shares hit a yearly low of $18.38. The stock was down 1.13% on the session. Atlantic Union Bankshares (NYSE:AUB) shares moved down 4.07% on Thursday to hit a new 52-week low of $23.34, drifting down 4.07%. Pacific Premier Bancorp (NASDAQ:PPBI) shares were down 1.94% for the day, having made a 52-week low of $17.66. Frontier Group Holdings (NASDAQ:ULCC) stock achieved a new 52-week low on Thursday morning, hitting $7.61 and moving down 15.46%. HighPeak Energy (NASDAQ:HPK) shares reached a new 52-week low of $14.92 on Thursday morning, moving up 0.32%. Fulton Financial (NASDAQ:FULT) stock broke to a new 52-week low of $10.08 on Thursday. Shares of the company traded down 4.32%. Park Ntl (AMEX:PRK) stock set a new 52-week low of $100.50 on Thursday, moving down 0.19%. Towne Bank (NASDAQ:TOWN) shares fell to $21.31 on Thursday, setting a new 52-week low with a shift of down 0.18%. Washington Federal (NASDAQ:WAFD) stock achieved a new 52-week low on Thursday morning, hitting $23.90 and moving down 2.18%. Seacoast Banking (NASDAQ:SBCF) stock achieved a new 52-week low on Thursday morning, hitting $17.93 and moving down 1.38%. First Merchants (NASDAQ:FRME) stock hit a yearly low of $25.20. The stock was down 2.76% for the day. CSG Systems Intl (NASDAQ:CSGS) stock hit a new 52-week low of $48.92. The stock was down 3.35% on the session. Hanesbrands (NYSE:HBI) stock dropped to a yearly low on Thursday of $4.34. Shares traded down 9.84%. Banner (NASDAQ:BANR) stock achieved a new 52-week low on Thursday morning, hitting $42.29 and moving down 3.02%. AdaptHealth (NASDAQ:AHCO) stock achieved a new 52-week low on Thursday morning, hitting $11.01 and moving down 3.85%. Claros Mortgage Trust (NYSE:CMTG) stock dropped to a yearly low on Thursday of $10.51. Shares traded down 3.03%. ProFrac Holding (NASDAQ:ACDC) shares made a new 52-week low of $9.17 on Thursday. The stock was down 1.8% for the day. NV5 Global (NASDAQ:NVEE) shares moved up 0.97% on Thursday to hit a new 52-week low of $91.42, drifting up 0.97%. Renasant (NASDAQ:RNST) stock hit a new 52-week low of $24.82. The stock was up 0.74% on the session. Elme Communities (NYSE:ELME) stock hit a yearly low of $16.22. The stock was up 0.76% for the day. Enterprise Finl Servs (NASDAQ:EFSC) stock drifted down 3.25% on Thursday morning to hit a new 52-week low of $36.16. Revolve Gr (NYSE:RVLV) stock drifted down 4.52% on Thursday morning to hit a new 52-week low of $17.02. BankUnited (NYSE:BKU) stock achieved a new 52-week low on Thursday morning, hitting $16.53 and moving down 5.1%. Trustmark (NASDAQ:TRMK) shares set a new 52-week low of $20.74. The stock traded down 0.46%. StepStone Group (NASDAQ:STEP) stock hit a new 52-week low of $20.82. The stock was down 2.18% on the session. Udemy (NASDAQ:UDMY) shares set a new yearly low of $8.17 this morning. The stock was up 3.82% on the session. Northwest Bancshares (NASDAQ:NWBI) shares set a new 52-week low of $9.91. The stock traded down 2.54%. Stock Yards Bancorp (NASDAQ:SYBT) stock dropped to a yearly low on Thursday of $42.59. Shares traded down 2.98%. Veradigm (NASDAQ:MDRX) stock drifted down 0.42% on Thursday morning to hit a new 52-week low of $11.61. Pactiv Evergreen (NASDAQ:PTVE) shares set a new yearly low of $6.98 this morning. The stock was down 0.42% on the session. Wesbanco (NASDAQ:WSBC) shares set a new 52-week low of $19.90. The stock traded down 3.46%. Independent Bank Gr (NASDAQ:IBTX) shares hit a yearly low of $28.81. The stock was down 4.58% on the session. Arvinas (NASDAQ:ARVN) shares reached a new 52-week low of $22.15 on Thursday morning, moving down 4.65%. NBT Bancorp (NASDAQ:NBTB) shares set a new yearly low of $27.52 this morning. The stock was down 2.72% on the session. Sabre (NASDAQ:SABR) shares made a new 52-week low of $3.54 on Thursday. The stock was down 5.19% for the day. First Commonwealth (NYSE:FCF) shares made a new 52-week low of $11.33 on Thursday. The stock was down 1.49% for the day. Heartland Financial USA (NASDAQ:HTLF) shares moved down 4.84% on Thursday to hit a new 52-week low of $27.53, drifting down 4.84%. FB Financial (NYSE: